ASTRAZENECA WKN: 886455 ISIN: GB0009895292 Forum: Aktien Thema: Hauptdiskussion

🦅💨💨💨

23 March 2021 11:45 GMT The numbers published yesterday were based on a pre-specified interim analysis with a data cut-off of 17 February. We have reviewed the preliminary assessment of the primary analysis and the results were consistent with the interim analysis. We are now completing the validation of the statistical analysis. We will immediately engage with the independent data safety monitoring board (DSMB) to share our primary analysis with the most up to date efficacy data. We intend to issue results of the primary analysis within 48 hours.

FDA ist entscheidend

Was ist da nur los?! Aber egal, der Kurs wird keinen Schaden nehmen

https://health.economictimes.indiatimes.com/news/pharma/astrazeneca-may-have-provided-incomplete-efficacy-data-from-latest-covid-19-trial-niaid/81647587

Wer short eingegangen ist, selber Schuld 🤑

Der altmodische Diesel von Astra stottert weiter vor sich hin.. https://www.google.de/amp/s/amp.tagesspiegel.de/wissen/nach-astrazeneca-impfung-krankenhausmitarbeiter-in-daenemark-gestorben/27026230.html

Die Trolle können sagen, was ihr wollen. FDA Zulassung folgt

The AstraZeneca US Phase III trial of AZD1222 demonstrated statistically significant vaccine efficacy of 79% at preventing symptomatic COVID-19 and 100% efficacy at preventing severe disease and hospitalisation. This interim safety and efficacy analysis was based on 32,449 participants accruing 141 symptomatic cases of COVID-19. The trial had a 2:1 randomisation of vaccine to placebo. Vaccine efficacy was consistent across ethnicity and age. Notably, in participants aged 65 years and over, vaccine efficacy was 80%.

schaut gut aus 🤔

https://www.google.at/amp/s/amp.cnn.com/cnn/2021/03/22/health/astrazeneca-vaccine-efficacy-us-based-clinical-trial/index.html

1,1/10 🤣🤣🤣

Dito